Skip to main content
Erschienen in: Pediatric Nephrology 5/2008

01.05.2008 | Original Article

Comparison of glomerular function tests in children with cancer

verfasst von: Marika H. Grönroos, Timo Jahnukainen, Kerttu Irjala, Risto Härkönen, Saija Hurme, Merja Möttönen, Toivo T. Salmi

Erschienen in: Pediatric Nephrology | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Evaluation of renal function should be performed as part of the follow-up during and after chemotherapy in pediatric cancer patients. The aim of this study was to compare an isotope clearance method [isotope glomerular filtration rate (iGFR)] with alternative methods to determine GFR in such patients. Isotope GFR [99mTc-labeled diethylene triaminopentoacetic acid (DTPA) or 51Cr-labeled ethylenediaminetetra-acetate (EDTA)] was measured in 36 children (112 studies) and compared with simultaneously measured creatinine clearance (CrCl), serum creatinine (SCr), and cystatin C (CysC) concentrations, as well as the results of Schwartz, Counahan–Barratt, and Cockroft–Gault formulae, using general linear mixed models. Our results showed a significant association between iGFR and CysC concentrations (p < 0.001). No linear relationship was observed between CrCl and iGFR (p = 0.7). As expected, the results of height-based formulae (Counahan–Barratt and Schwartz) had significantly (p = 0.004) better correlation to iGFR than the results of a formula based on weight (Cockroft–Gault) (p = 0.19). Despite significant linear correlation, intraclass correlation coefficients showed poor agreement. Tests of similarity between iGFR estimates showed differences between average values of GFR. Therefore, determination of iGFR remains the method of choice in estimation of GFR in cancer patients. In our study population, assay of serum CysC was the most reliable alternative method to measure glomerular function.
Literatur
1.
Zurück zum Zitat Loebstein R, Atanackovic G, Bishai R, Wolpin J, Khattak S, Hashemi G, Gobrial M, Baruchel S, Ito S, Koren G (1999) Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 39:454–461PubMed Loebstein R, Atanackovic G, Bishai R, Wolpin J, Khattak S, Hashemi G, Gobrial M, Baruchel S, Ito S, Koren G (1999) Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 39:454–461PubMed
2.
Zurück zum Zitat Rossi R, Kleta R, Ehrich JH (1999) Renal involvement in children with malignancies. Pediatr Nephrol 13:153–162CrossRefPubMed Rossi R, Kleta R, Ehrich JH (1999) Renal involvement in children with malignancies. Pediatr Nephrol 13:153–162CrossRefPubMed
3.
Zurück zum Zitat Skinner R (1995) Strategies to prevent nephrotoxicity of anticancer drugs. Curr Opin Oncol 7:310–315CrossRefPubMed Skinner R (1995) Strategies to prevent nephrotoxicity of anticancer drugs. Curr Opin Oncol 7:310–315CrossRefPubMed
4.
Zurück zum Zitat Suarez A, McDowell H, Niaudet P, Comoy E, Flamant F (1991) Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: An International Society of Pediatric Oncology Report. J Clin Oncol 9:2177–2182CrossRefPubMed Suarez A, McDowell H, Niaudet P, Comoy E, Flamant F (1991) Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: An International Society of Pediatric Oncology Report. J Clin Oncol 9:2177–2182CrossRefPubMed
5.
Zurück zum Zitat Schwartz GJ, Furth SL (2007) Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol 22:1839–1848CrossRefPubMed Schwartz GJ, Furth SL (2007) Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol 22:1839–1848CrossRefPubMed
6.
Zurück zum Zitat Gaspari F, Perico N, Remuzzi G (1997) Measurement of glomerular filtration rate. Kidney Int Suppl 63:S151–S154PubMed Gaspari F, Perico N, Remuzzi G (1997) Measurement of glomerular filtration rate. Kidney Int Suppl 63:S151–S154PubMed
7.
Zurück zum Zitat Piepsz A, Colarinha P, Gordon I, Hahn K, Olivier P, Sixt R, van Velzen J, Paediatric Committee of the European Association of Nuclear Medicine (2001) Guidelines for glomerular filtration rate determination in children. Eur J Nucl Med 28:BP31–BP36PubMed Piepsz A, Colarinha P, Gordon I, Hahn K, Olivier P, Sixt R, van Velzen J, Paediatric Committee of the European Association of Nuclear Medicine (2001) Guidelines for glomerular filtration rate determination in children. Eur J Nucl Med 28:BP31–BP36PubMed
8.
Zurück zum Zitat Rehling M, Moller ML, Thamdrup B, Lund JO, Trap-Jensen J (1984) Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci 66:613–619CrossRef Rehling M, Moller ML, Thamdrup B, Lund JO, Trap-Jensen J (1984) Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci 66:613–619CrossRef
9.
Zurück zum Zitat Effersoe H, Rosenkilde P, Groth S, Jensen LI, Golman K (1990) Measurement of renal function with iohexol. A comparison of iohexol, 99mTc-DTPA, and 51Cr-EDTA clearance. Invest Radiol 25:778–782CrossRefPubMed Effersoe H, Rosenkilde P, Groth S, Jensen LI, Golman K (1990) Measurement of renal function with iohexol. A comparison of iohexol, 99mTc-DTPA, and 51Cr-EDTA clearance. Invest Radiol 25:778–782CrossRefPubMed
10.
Zurück zum Zitat Laterza OF, Price CP, Scott MG (2002) Cystatin C: An improved estimator of glomerular filtration rate? Clin Chem 48:699–707PubMed Laterza OF, Price CP, Scott MG (2002) Cystatin C: An improved estimator of glomerular filtration rate? Clin Chem 48:699–707PubMed
11.
Zurück zum Zitat Stickle D, Cole B, Hock K, Hruska KA, Scott MG (1998) Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem 44:1334–1338PubMed Stickle D, Cole B, Hock K, Hruska KA, Scott MG (1998) Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem 44:1334–1338PubMed
12.
Zurück zum Zitat Ylinen EA, Ala-Houhala M, Harmoinen AP, Knip M (1999) Cystatin C as a marker for glomerular filtration rate in pediatric patients. Pediatr Nephrol 13:506–509CrossRefPubMed Ylinen EA, Ala-Houhala M, Harmoinen AP, Knip M (1999) Cystatin C as a marker for glomerular filtration rate in pediatric patients. Pediatr Nephrol 13:506–509CrossRefPubMed
13.
Zurück zum Zitat Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J (1998) Cystatin C – a new marker of glomerular filtration rate in children independent of age and height. Pediatrics 101:875–881CrossRefPubMed Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J (1998) Cystatin C – a new marker of glomerular filtration rate in children independent of age and height. Pediatrics 101:875–881CrossRefPubMed
14.
Zurück zum Zitat Lankisch P, Wessalowski R, Maisonneuve P, Haghgu M, Hermsen D, Kramm CM (2006) Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age. Pediatr Blood Cancer 46:767–772CrossRefPubMed Lankisch P, Wessalowski R, Maisonneuve P, Haghgu M, Hermsen D, Kramm CM (2006) Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age. Pediatr Blood Cancer 46:767–772CrossRefPubMed
15.
Zurück zum Zitat Stabuc B, Vrhovec L, Stabuc-Silih M, Cizej TE (2000) Improved prediction of decreased creatinine clearance by serum cystatin C: Use in cancer patients before and during chemotherapy. Clin Chem 46:193–197PubMed Stabuc B, Vrhovec L, Stabuc-Silih M, Cizej TE (2000) Improved prediction of decreased creatinine clearance by serum cystatin C: Use in cancer patients before and during chemotherapy. Clin Chem 46:193–197PubMed
16.
Zurück zum Zitat Hjorth L, Wiebe T, Karpman D (2002) Correct evaluation of renal glomerular filtration rate requires clearance assays. Pediatr Nephrol 17:847–851CrossRefPubMed Hjorth L, Wiebe T, Karpman D (2002) Correct evaluation of renal glomerular filtration rate requires clearance assays. Pediatr Nephrol 17:847–851CrossRefPubMed
17.
Zurück zum Zitat Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Makipernaa A, Nygaard R, Saarinen-Pihkala UM (2000) Improving outcome through two decades in childhood ALL in the Nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 14:2267–2275CrossRefPubMed Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Makipernaa A, Nygaard R, Saarinen-Pihkala UM (2000) Improving outcome through two decades in childhood ALL in the Nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 14:2267–2275CrossRefPubMed
18.
Zurück zum Zitat Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310CrossRefPubMed Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310CrossRefPubMed
19.
Zurück zum Zitat Bardi E, Bobok I, Olah AV, Olah E, Kappelmayer J, Kiss C (2004) Cystatin C is a suitable marker of glomerular function in children with cancer. Pediatr Nephrol 19:1145–1147CrossRefPubMed Bardi E, Bobok I, Olah AV, Olah E, Kappelmayer J, Kiss C (2004) Cystatin C is a suitable marker of glomerular function in children with cancer. Pediatr Nephrol 19:1145–1147CrossRefPubMed
20.
Zurück zum Zitat Blaufox MD (1991) Procedures of choice in renal nuclear medicine. J Nucl Med 32:1301–1309PubMed Blaufox MD (1991) Procedures of choice in renal nuclear medicine. J Nucl Med 32:1301–1309PubMed
21.
Zurück zum Zitat Ditzel J, Vestergaard P, Brinklov M (1972) Glomerular filtration rate determined by 51Cr-EDTA-complex. A practical method based upon the plasma disappearance curve determined from four plasma samples. Scand J Urol Nephrol 6:166–170CrossRefPubMed Ditzel J, Vestergaard P, Brinklov M (1972) Glomerular filtration rate determined by 51Cr-EDTA-complex. A practical method based upon the plasma disappearance curve determined from four plasma samples. Scand J Urol Nephrol 6:166–170CrossRefPubMed
22.
Zurück zum Zitat Barbour GL, Crumb CK, Boyd CM, Reeves RD, Rastogi SP, Patterson RM (1976) Comparison of inulin, iothalamate, and 99mTc-DTPA for measurement of glomerular filtration rate. J Nucl Med 17:317–320PubMed Barbour GL, Crumb CK, Boyd CM, Reeves RD, Rastogi SP, Patterson RM (1976) Comparison of inulin, iothalamate, and 99mTc-DTPA for measurement of glomerular filtration rate. J Nucl Med 17:317–320PubMed
23.
Zurück zum Zitat Narayanan S, Appleton HD (1980) Creatinine: A review. Clin Chem 26:1119–1126PubMed Narayanan S, Appleton HD (1980) Creatinine: A review. Clin Chem 26:1119–1126PubMed
24.
Zurück zum Zitat Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 38:1933–1953PubMed Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 38:1933–1953PubMed
25.
Zurück zum Zitat Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS, National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (2003) National Kidney Foundation’s kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: Evaluation, classification, and stratification. Pediatrics 111:1416–1421CrossRefPubMed Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS, National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (2003) National Kidney Foundation’s kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: Evaluation, classification, and stratification. Pediatrics 111:1416–1421CrossRefPubMed
26.
Zurück zum Zitat Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G, National Kidney Foundation (2003) National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139:137–147CrossRefPubMed Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G, National Kidney Foundation (2003) National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139:137–147CrossRefPubMed
27.
Zurück zum Zitat National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification, part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease guideline 4. Estimation of GFR. Am J Kidney Dis 39:S76–S110CrossRef National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification, part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease guideline 4. Estimation of GFR. Am J Kidney Dis 39:S76–S110CrossRef
28.
Zurück zum Zitat Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263PubMed Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263PubMed
29.
Zurück zum Zitat Schwartz A, Gauthier B (1985) Simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522–526CrossRefPubMed Schwartz A, Gauthier B (1985) Simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522–526CrossRefPubMed
30.
Zurück zum Zitat Filler G, Foster J, Acker A, Lepage N, Akbari A, Ehrich JH (2005) The Cockcroft–Gault formula should not be used in children. Kidney Int 67:2321–2324CrossRefPubMed Filler G, Foster J, Acker A, Lepage N, Akbari A, Ehrich JH (2005) The Cockcroft–Gault formula should not be used in children. Kidney Int 67:2321–2324CrossRefPubMed
31.
Zurück zum Zitat Pierrat A, Gravier E, Saunders C, Caira MV, Ait-Djafer Z, Legras B, Mallie JP (2003) Predicting GFR in children and adults: A comparison of the Cockcroft–Gault, Schwartz, and modification of diet in renal disease formulas. Kidney Int 64:1425–1436CrossRefPubMed Pierrat A, Gravier E, Saunders C, Caira MV, Ait-Djafer Z, Legras B, Mallie JP (2003) Predicting GFR in children and adults: A comparison of the Cockcroft–Gault, Schwartz, and modification of diet in renal disease formulas. Kidney Int 64:1425–1436CrossRefPubMed
32.
Zurück zum Zitat Grubb A (1992) Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 38(Suppl 1):S20–S27PubMed Grubb A (1992) Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 38(Suppl 1):S20–S27PubMed
33.
Zurück zum Zitat Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, Grubb A (1990) Structure and expression of the human cystatin C gene. Biochem J 268:287–294CrossRefPubMedPubMedCentral Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, Grubb A (1990) Structure and expression of the human cystatin C gene. Biochem J 268:287–294CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela SL, Irjala K (2003) Serum cystatin C in the aged: Relationships with health status. Am J Kidney Dis 42:36–43CrossRefPubMed Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela SL, Irjala K (2003) Serum cystatin C in the aged: Relationships with health status. Am J Kidney Dis 42:36–43CrossRefPubMed
35.
Zurück zum Zitat Risch L, Herklotz R, Blumberg A, Huber AR (2001) Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 47:2055–2059PubMed Risch L, Herklotz R, Blumberg A, Huber AR (2001) Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 47:2055–2059PubMed
36.
Zurück zum Zitat Finney H, Williams AH, Price CP (2001) Serum cystatin C in patients with myeloma. Clin Chim Acta 309:1–6CrossRefPubMed Finney H, Williams AH, Price CP (2001) Serum cystatin C in patients with myeloma. Clin Chim Acta 309:1–6CrossRefPubMed
37.
Zurück zum Zitat Mulaomerovic A, Halilbasic A, Cickusic E, Zavasnik-Bergant T, Begic L, Kos J (2007) Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma. Cancer Lett 248:192–197CrossRefPubMed Mulaomerovic A, Halilbasic A, Cickusic E, Zavasnik-Bergant T, Begic L, Kos J (2007) Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma. Cancer Lett 248:192–197CrossRefPubMed
38.
Zurück zum Zitat Kos J, Stabuc B, Cimerman N, Brunner N (1998) Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem 44:2556–2557PubMed Kos J, Stabuc B, Cimerman N, Brunner N (1998) Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem 44:2556–2557PubMed
39.
Zurück zum Zitat Mojiminiyi OA, Marouf R, Abdella N, Kortom M, Abdul-Razzak R (2002) Serum concentration of cystatin C is not affected by cellular proliferation in patients with proliferative haematological disorders. Ann Clin Biochem 39:308–310CrossRefPubMed Mojiminiyi OA, Marouf R, Abdella N, Kortom M, Abdul-Razzak R (2002) Serum concentration of cystatin C is not affected by cellular proliferation in patients with proliferative haematological disorders. Ann Clin Biochem 39:308–310CrossRefPubMed
Metadaten
Titel
Comparison of glomerular function tests in children with cancer
verfasst von
Marika H. Grönroos
Timo Jahnukainen
Kerttu Irjala
Risto Härkönen
Saija Hurme
Merja Möttönen
Toivo T. Salmi
Publikationsdatum
01.05.2008
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 5/2008
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-007-0722-9

Weitere Artikel der Ausgabe 5/2008

Pediatric Nephrology 5/2008 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.